老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Armata Pharmaceuticals, Inc.

6.71
-0.6100-8.33%
盘后：6.710.00000.00%16:10 EST
成交量：19.88万
成交额：127.53万
市值：2.44亿
市盈率：-4.97
高：7.25
开：7.17
低：5.83
收：7.32
52周最高：16.34
52周最低：0.8981
股本：3,632.98万
流通股本：1,087.46万
量比：1.47
换手率：1.83%
股息：- -
股息率：- -
每股收益(TTM):-1.3506
每股收益(LYR):-0.5231
净资产收益率：-3439.35%
总资产收益率：-22.20%
市净率：-2.55
市盈率(LYR):-12.83

数据加载中...

总览公司新闻资讯公告
2021/05/14

重要事件披露

8-K - Current report
2021/05/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/05

重要事件披露

8-K - Current report
2021/04/05

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/03/18

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/17

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/03/17

重要事件披露

8-K - Current report
2021/02/22

SEC问询函

CORRESP [Cover] - Correspondence
2021/01/27

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/27

重要事件披露

8-K - Current report
2021/01/06

重要事件披露

8-K - Current report
2020/12/09

重要事件披露

8-K - Current report
2020/11/12

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/11/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/06/18

重要事件披露

8-K - Current report
2020/05/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/04/28

重要事件披露

8-K - Current report
2020/04/06

SEC问询函

CORRESP [Cover] - Correspondence
2020/04/06

SEC问询函

CORRESP [Cover] - Correspondence
更多